[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100502326":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":8,"responsibleParty":25,"collaborators":7,"id":29,"slug":7,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":33,"acronym":7,"eligibilityCriteria":34,"healthyVolunteers":35,"sex":36,"minAge":37,"maxAge":38,"enrollmentInfo":39,"targetDuration":7,"studyType":42,"phases":7,"briefSummary":43,"conditions":44,"keywords":7,"overallStatus":10,"whyStopped":7,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":56},{"fullName":5,"class":6},"Seoul National University Hospital","OTHER",null,[9],{"facility":5,"status":10,"city":11,"state":7,"zip":7,"country":12,"countryCode":7,"cosmosGeoPoint":13,"geoPoint":18,"contacts":19},"RECRUITING","Seoul","South Korea",{"type":14,"coordinates":15},"Point",[16,17],126.9784,37.566,{"lat":17,"lon":16},[20],{"name":21,"role":22,"phone":23,"phoneExt":7,"email":24},"Young-Eun Jang, MD, PhD","CONTACT","82-2-2072-3650","na0ag2@hotmail.com",{"type":26,"investigatorFullName":27,"investigatorTitle":28,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Young-Eun Jang","Clinical Associate Professor","100502326",false,"NCT05820802","High Dimensional Analysis of Immune Cells in Pediatric Patients","High Dimensional Analysis of Immune Cells Using scRNA-seq in Pediatric Patients With Allergic Reactions to Neuromuscular Blockers","Inclusion Criteria:\n\n* Pediatric patients between the ages of 2 and 18 undergoing general anesthesia and surgery using the neuromuscular blocker, rocuronium.\n\nExclusion Criteria:\n\n* Patients who have received immunomodulators, immunosuppressants, etc.\n* Patients with autoimmune diseases (rheumatoid arthritis, lupus, Behcet's disease, etc.)\n* Patients who regularly take, or have taken within 4 weeks, medications that may affect the immune system (oral steroids, anti-inflammatories, etc.)\n* Other cases where the Principal Investigator determines that it is difficult to conduct the study.",true,"ALL","2 Years","18 Years",{"count":40,"type":41},294,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to characterize immune cells using single-cell transcriptomic analysis in pediatric patients aged 2 to 18 years undergoing general anesthesia who are expected to receive Rocuronium, a non-depolarizing neuromuscular blocking agent, in the event of an allergic reaction.",[45,46],"Drug Allergy","Neuromuscular Blockade","2024-11-26",{"date":49,"type":50},"2024-11-29","ACTUAL",{"date":52,"type":50},"2023-04-27",{"date":54,"type":41},"2026-12-01",{"name":5,"class":6},1]